Name: 15th Annual Immunogenicity & Bioassay Summit
Start: 2023-10-02
End: 2023-10-05

15th Annual Immunogenicity & Bioassay Summit

02
Oct

05
Oct

2023

When

Washington, DC

USA

Where

CHI is excited to host its 15th Annual Immunogenicity & Bioassay Summit in Washington, D.C. We’ll examine challenges facing the industry with NEW case studies, NEW perspectives and NEW approaches. Learn from the industry, academia and the regulatory authorities at 3 Conference Programs, Symposium, Workshop and several Short Courses. Once again, we’ll host interactive breakouts on various niche topics so delegates can share experiences and generate new ideas. Plus, attend an exhibit and poster hall with innovative products and services.

Why Attend

15th Annual Immunogenicity & Bioassay Summit

Stay at the forefront of immunogenicity assessment and its impact on drug development.

Grow

Strengthen your expertise and gain a deeper understanding of immunogenicity assessment by delving into the intricate interplay of regulatory considerations, best practices, and emerging trends.

Experience

Expand your knowledge further by actively participating in a symposium, workshop, and a series of short courses, allowing you to benefit from a multifaceted approach and diverse educational opportunities.

Be inspired

Gain valuable insights from keynote speakers who are trailblazers and pioneers in the field of immunogenicity assessment, renowned for their substantial contributions to the realm of drug development.

Similar Events

Cambridge Healthtech Institute

0/5

(0)

Cambridge Healthtech Institute – Your Life Science Network Cambridge Healthtech Institute (CHI) is the preeminent life science network for leading researchers and business experts from top pharmaceutical, biotech and academic organizations.

02 - 05 Oct 2023

Hybrid

Speakers and Delegates
Industry Experts and Thought Leaders

Kristina Howard

Research Veterinary Medical Officer

FDA

Ronit Mazor

Principal Investigator

FDA

Zuben Sauna

Director, Division of Hemostasis

FDA

Anurag Sharma

Gene Therapy Reviewer

FDA

Yow-Ming Wang

Associate Director for Biosimilars and Therapeutic Biologics, Office of Clinical Pharmacologyd

FDA

Sponsors and Exhibitors
Brand, Media and Promotional Partners

Gyros Protein Technologies

Gyros Protein Technologies provides enabling peptide synthesis and immunoassay bioanalytical tools that help scientists increase biomolecule performance and productivity in research, drug discovery, pre-clinical and clinical development, and bioproce

Gyros Protein Technologies

ProImmune

ProImmune’s mission is to be your partner of choice for understanding and managing adaptive immune responses.

ProImmune

ProImmune’s mission is to be your partner of choice for understanding and managing adaptive immune responses.

Amador Bioscience

Amador Bioscience is a Translational & Clinical CRO providing global-standard quantitative clinical pharmacology, GLP/GCLP bioanalysis, clinical research, and regulatory filing services to biopharmaceutical companies in China, USA and EU. Amador is c

Amador Bioscience

Stegmann Systems GmbH

Is complexity something bad? We don’t think so. For us, complexity is just a fact of life. There is no point in simplifying something when you’re really just throwing away valuable information. The best thing we can do about complexity is to make it

Why Attend

15th Annual Immunogenicity & Bioassay Summit